The European Summit on Pharma and Biotech Patent Litigation took place and was a huge success, with over 150 members of the IP community joining together in 2 days of riveting discussion and interactive sessions. The event proved to be a key opportunity for professionals working in Intellectual Property law, Patent Strategist, Senior Counsel, or IP to meet, share innovations and benchmark success. We can't wait for 2023 to deliver another exciting agenda to the community.

Read on pharmabiotechpatentlitigation.com

RNA technologies have taken the world by storm over the pandemic and now the potential to of RNA engineering to enhance cell therapy is finally being realized.

The therapeutic potential of RNA cell therapies is huge, but challenges remain in cell-specific delivery, improving durability of responses, demonstrating safety and elucidating regulatory considerations to deliver for patients.

The inaugural RNA Cell Therapy Summit is the first of its kind to unite 80+ industry and academic pioneers from both the RNA and cell therapy field to bridge-the-gap between transient RNA engineering and cell therapy development.

Join industry trailblazers at BioNTech, Sanofi, Intellia, Editas, Capstan and more to future-proof your pipeline with the pinnacle of cell engineering to develop the next-generation of safer, more functional and scalable cell therapies through the clinic.

Time: 09:00 to 15:00

Built with biopharmaceutical industry insights, this in-person meeting will bring together KOLs to delve deep into the key remaining challenges when it comes to identifying, designing and developing the next generation of molecular glues and truly unlock the widespread therapeutic potential of this promising therapy.

This forum will deliver exclusive data from the movers and shakers in the molecular glue space, from the likes of C4 Therapeutics, Monte Rosa Therapeutics, Amgen, Proxygen, Pin Therapeutics, Degron Therapeutics, Plexium and more.

As we continue enriching the design and development of molecular glues, network with 80+ leading Chemists, Biologists, Bioinformaticians, Structural Scientists and Computational Chemists at the world's first-of-a-kind meeting to successfully accelerate the first wave of molecular glues into the clinic.

Time: 8:00 am - 5:00 pm

Every health system is focused on providing high-quality care, but the growth of consumerism bolstered by pandemic-related changes in patients’ habits and preferences is motivating healthcare organizations to ensure they’re delivering a high-quality, convenient patient experience. Healthcare organizations that want to attract and retain patients need to ensure they’re providing a top-notch experience that meets patients’ expectations. Focusing on improving the patient experience can give provider organizations a competitive edge in an increasingly crowded healthcare landscape. Join us on Tuesday, January 24 at 1PM ET (10AM PT) as Rob Gavora, Interim Vice President of MercyOne Children’s Hospital and Clinics, discusses how he has designed his health system’s digital front door to not only support key functions like intake, access and payments, but also to provide an experience that builds patient loyalty and trust. We’ll share how MercyOne is enabling experiences that increase volume and engage patients to take an active role in their care.

Read on go.beckershospitalreview.com

Join us for the 2023 Employers’ Summit on Health Care Cost & Delivery on January 24-25 at the Hyatt Regency Capitol Hill in Washington, DC.

• Collaborate and discuss solutions for providing more cost-effective and high value benefits and managing cost pressures.
• Gather insights and examples of how your peers are transforming programs and plan designs they have leveraged in the past to be better prepared for future priorities and challenges.

Now more than ever employers are leading the way toward transforming the delivery of health care to help improve affordability, navigation, integration and access to quality care. The Employers’ Summit on Health Care Cost & Delivery in January 2022, provided a unique forum for employers to connect, share and learn about best practices that drive toward health care quality and value while keeping costs in check.

Read on businessgrouphealth.org

The 2023 Summit theme will be Public Health 3.0, reflecting a wide range of issues and events facing us today. Please save the date for the hybrid online/in-person conference taking place from Tuesday, January 24, 2023, to Thursday, January 26, 2023! The in-person venue will be the Cuddy Center on the campus of the University of Alaska Anchorage. The 2023 Summit will feature keynote speakers and panels addressing tuberculosis treatment and care across Alaska, climate change, training of new public health workers, and an overview of Public Health 3.0 from an Alaska perspective. In addition, there will be many presentations highlighting the ongoing work of Alaska’s public health researchers and program directors. As always, any health professionals who attend will have the opportunity to earn continuing education credits.

Read on eventbrite.co.uk

With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers & researchers advantages that weren’t available to them even a few years ago is increasing rapidly. Despite this growth over the last 12 months, the IO community still faces critical challenges in translating drugs to the clinic. The IO community must continue to work together to overcome critical bottlenecks around immunomodulating agent utilization, dosing and efficacy as well as looking for predictive biomarkers to boost our clinical and therapeutic index confidence. 

Read on tumor-models-sf.com

DNA damage response inhibition has amassed a lot of interest over the last decade as it exposes a massive vulnerability in cancer cells. This has a huge potential to treat many types of tumors such as breast and colorectal cancers, and even notoriously difficult-to-treat CNS tumors.

The 6th Annual DDR Inhibitors Summit will cover both the preclinical and clinical DDR inhibitor landscape and establish how the field is addressing the biggest hurdle to drug development – toxicity. From reviewing progress with both novel and established targets to utilizing inhibitors in combination studies and improving patient selection with improved biomarkers; this meeting will give a comprehensive and up-to-date overview of the field.

As we look to 2023 and what it has in store, this highly anticipated summit is back in person, bigger and better than ever before. As the industry-leading conference, join forward-thinking researchers from the pharmaceutical, biotech and academic community as they unite to share ideas on progress, challenges and novel solutions in the current DDRi climate.

Prices:

FULL PACKAGE: Conference + Pre-Conference Day - Drug Developer USD 4946.00

Conference Only - Drug Developer USD 2999.00

FULL PACKAGE: Conference + Pre-Conference Day - Academic USD 4246.00

Conference Only - Academic USD 2599.00

FULL PACKAGE: Conference + Pre-Conference Day - Solution Provider USD 5846.00

Conference Only - Solution Provider USD 3599.00

Category: Conferences | Science, Health & Medicine | Pharmaceuticals | Drug Development

Dates and Time: Starts: Tue, Jan 24, 2023 ( 9:00 AM) and Ends: Thu, Jan 26, 2023 ( 6:00 PM)

Venue details: Crowne Plaza Boston - Woburn, an IHG Hotel, 15 Middlesex Canal Park Drive, Woburn, Massachusetts, 01801, United States

With an improved understanding of biology and mechanisms of action, the Wnt/B-Catenin community is surging through clinic in 2022 with positive clinical updates. The excitement of a potential first-in-class candidate to advent combination, immuno-oncology therapies in colorectal, head and neck and non-small cell lung cancer is offering hope for patients with high unmet medical needs.

After 2 decades of research, it is now the time for drug developers to act and get together at the 2nd Wnt/B-Catenin Pathway Targeted Drug Development Summit. As the one and only industry-led meeting, you will be equipped with unparalleled insights in:

- Wnt/B-Catenin's structural biology and medicinal chemistry - turning the undruggable druggable

- Comparison of different Wnt/B-Catenin modulation approaches, its interaction with TIL and tumor microenvironment for targeted, combination therapies

- Translating basic science into clinical design - from scheduling to dosing, overcoming toxicity to widen the therapeutic window with safety in mind

- Validating a clinical biomarker for patient selection

In collaboration with Wnt/B-Catenin pioneers such as Iterion Therapeutics, Leap Therapeutics, FogPharma, this is your unique opportunity to join and meet 60+ drug developers to forge long-term collaboration and advance Wnt/B-Catenin as a valuable target and clinical asset, propelling to provide first-in-class treatments for patients!

SAE Media Group is proud to present the 2nd annual Transdermal and Microneedle Drug Delivery Conference, taking place on the 23rd to 24th January 2023.

The 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization. Engage in the latest innovations in device design, development and formulation, with case studies from expert key opinion leaders of this rapidly accelerating space. Other key areas will be microneedle vaccines and transdermal patches for management of chronic disease.

The two-day agenda offers you peer-to-peer networking with CEO's, Senior Vice presidents, Directors, Heads of Product Development and many more.

BENEFITS OF ATTENDING:

- Engage with senior industry opinion leaders presenting their experiences and case studies in innovative device design and advanced drug product formulation

- Gain insights from notified body and competent authority representatives addressing key regulatory requirements

- Understand how to optimize your lifecycle management strategy for a commercially successful device

- Explore and benchmark against industry advances in device design through case studies and real-world examples

WHO SHOULD ATTEND:

- Drug-Delivery Device Developers

- Microneedle Device Developers

- Transdermal Delivery Developers

- Microarray Patch Developers

- Medical Device Engineers

- Primary Packaging Material Designers

- Secondary Packagers

- Smart Device Developers

- Training Device Developers

- Device-Safety Solution Providers

- Drug Developers

- Transdermal Drug Product Developers

EARLY-BIRD RATES:

BOOK BY 30TH SEPTEMBER AND SAVE £400 

Registrations can be made on the event website at: www.transdermal-microneedle-delivery.co.uk/EVVNT 

Time: 09:00 to 17:00